How do you take magnesium L-threonate?

What the labels give
FormServingMagnesiumLabel direction
Capsules3 capsules1144 mg1Three capsules daily, with or without food, or as recommended by a healthcare practitioner1
Powder1 scoop (approx. 3.11 g) from 2000 mg Magtein3144 mg3One scoop daily with water or juice to taste, best taken with food, or as recommended by a healthcare practitioner3

The Life Extension labels give 3 capsules daily (144 mg magnesium from 2000 mg Magtein) or one scoop (about 3.11 g) of powder mixed with water or juice, and trials gave 1 to 2 g of magnesium L-threonate a day.12345

What the labels give

The table is set at the top of the page

The powder label gives no water volume, and no maker's leaflet giving one has been located.3 Strengths from other makers were not sourced. The capsule labels warn against exceeding the labelled dose and advise a physician if pregnant, lactating or under treatment.1

What the trials used

The authors of the Lopresti and Smith trial say Magtein is typically administered twice daily to maintain steady magnesium concentrations.5 The 2 g/day arm of the Zhang trial took a formula that also held phosphatidylserine and vitamins C and D, not Magtein alone.6

TrialDose and schedulePeopleLength
Hausenblas1 g/day, vs placebo4Eighty 35–55-year-olds with self-assessed sleep problems421 days4
Lopresti2 g/day of Magtein (145 mg elemental magnesium), one 1 g capsule in the morning and one in the evening 2 h before bedtime, vs placebo5100 adults aged 18 to 45 with self-reported dissatisfied sleep56 weeks5
Zhang2 g/day of Magtein PS (a formula), 2 capsules of 0.504 g in the morning and 2 in the evening before sleep, vs starch placebo6109 healthy Chinese adults aged 18 to 65630 days6
Liu (Miami)1.5 g/day (50 to 70 kg) or 2 g/day (70 to 100 kg) of MMFS-01, vs placebo7851 adults aged 50 to 70 enrolled; 23 on MMFS-01 and 21 on placebo812 weeks8

No label gives a cycle length or a loading schedule. The one multi-dose design in the pack is a registry entry (NCT03601169) for a three-way crossover in which older adults take placebo, low-dose and high-dose MMFS twice daily over three 2-week periods; no results were saved.9

Limits and label status

The pack's search located no US drug label or regulator-set dose for stand-alone magnesium L-threonate. The EFSA opinion records the applicant's intended maximum of 3000 mg a day in food supplements, about 250 mg magnesium, for the general adult population excluding pregnant and lactating women, and its panel concluded the ingredient is safe under those proposed conditions.7 EFSA reports 250 mg a day as the SCF upper level for supplemental magnesium from readily dissociable salts, on top of the magnesium from the background diet.7

Grams of compound and mg of magnesium

A dose in grams is the whole compound, and the magnesium in it is a smaller figure: the labels give 144 mg magnesium from 2000 mg Magtein.13 EFSA's specification puts magnesium at 7.2%–8.3% of the powder.7 The Hausenblas trial reports about 75 mg of elemental magnesium in 1 g of Magtein, and the Lopresti and Smith trial gives 145 mg for 2 g.45 EFSA's account of the Miami trial gives 1.5 g as providing about 124 mg magnesium and 2 g as providing 166 mg.7

Storage

Both Life Extension labels say to store tightly closed in a cool, dry place.13 EFSA reports stability of the ingredient powder assessed in its opinion in three batches at 25°C ± 2°C and 60% relative humidity ± 5% for 36 months.7 Storage after mixing was not found.

Frequently asked questions

What time of day is magnesium L-threonate taken in trials?

A recruiting University of Miami registry entry for 64 estimated participants undergoing knee or hip arthroplasty lists a daily 145 mg pill by mouth 30 minutes before going to sleep, for up to 6 weeks after surgery.10

References

  1. NIH DSLD (product label). Read the entire label and follow the directions carefully prior to use. api.ods.od.nih.gov
  2. NIH DSLD (product label). Read the entire label and follow the directions carefully prior to use. api.ods.od.nih.gov
  3. NIH DSLD (product label). Read the entire label and follow the directions carefully prior to use. api.ods.od.nih.gov
  4. PMC. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial. 2024. pmc.ncbi.nlm.nih.gov
  5. PMC. The effects of magnesium L-threonate (Magtein ® ) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. 2026. pmc.ncbi.nlm.nih.gov
  6. PMC. A Magtein ® , Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults. 2022. pmc.ncbi.nlm.nih.gov
  7. EFSA Journal (EFSA NDA Panel), via PMC. Safety of magnesium l ‐threonate as a novel food pursuant to regulation (EU) 2015/2283 and bioavailability of magnesium from this source in the context of Directive 2002/46/EC. 2024. pmc.ncbi.nlm.nih.gov
  8. PMC. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. 2015. pmc.ncbi.nlm.nih.gov
  9. ClinicalTrials.gov. NCT03601169: Comparison of MMFS Dosages in Older Adults. 2019. clinicaltrials.gov
  10. ClinicalTrials.gov. NCT06902285: Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty. 2027. clinicaltrials.gov